3.

104.
105.

106.

107.

108.

109.

110.
111.

112.

113.

114.

115.

threatening ischemia in diabetic patients. J Vasc Surg 2020;71:
1644e52.e2.
Hicks CW, Canner JK, Karagozlu H, Mathioudakis N, Sherman RL,
Black JH 3rd, et al. Quantifying the costs and proﬁtability of care for
diabetic foot ulcers treated in a multidisciplinary setting. J Vasc
Surg 2019;70:233-40.
Hicks CW, Canner JK, Sherman RL, Black JH 3rd, Lum YW,
Abularrage CJ. Evaluation of revascularization beneﬁt quartiles using the Wound, Ischemia, and foot Infection classiﬁcation system
for diabetic patients with chronic limb-threatening ischemia. J Vasc
Surg 2021;74:1232e9.e3.
Pena G, Kuang B, Edwards S, Cowled P, Dawson J, Fitridge R. Factors associated with key outcomes in diabetes related foot disease:
a prospective observational study. Eur J Vasc Endovasc Surg
2021;62:233-40.
Ricco JB, Gargiulo M, Stella A, Abualhin M, Gallitto E, Desvergnes M,
et al. Impact of angiosome- and nonangiosome-targeted peroneal
bypass on limb salvage and healing in patients with chronic limbthreatening ischemia. J Vasc Surg 2017;66:1479-87.
Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1996;11:153-7.
Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, Katsanos K,
et al. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a